Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cereno Scientific reports first patient dosed in Phase II study in PAH with drug candidate CS1

Cereno Scientific (XSAT: CRNO B) today announced that the first patient has received their first dose of drug candidate CS1 in the Phase II study in pulmonary arterial hypertension (PAH). Prior to the dosing, the patient has undergone a screening process, implantation of the CardioMEMS HF System to monitor lung pressure during the study, and a full baseline evaluation including a 6-minute walk test, echocardiography, and MRI to enable exploration of CS1’s efficacy. Each patient will undergo a 12-week drug treatment period and a two-week follow-up period. Drug candidate CS1 aims to offer a

Transfer of ownership in First Camp Group and change in the Board of Directors

First Camp Group AB’s (”First Camp Group” or the ”Company”) ultimate main shareholder Norvestor VII L.P., which is managed by Norvestor Investment Management S.a.r.l. (“Norvestor”) has sold its ownership in First Camp Group and certain other portfolio companies to Norvestor SPV II SCSp.Norvestor SPV II SCSp is a continuation fund, managed and advised by Norvestor. Thus, the sale does not constitute a change of ownership (change of control) pursuant to the terms and conditions for the Company’s outstanding bond loan. In connection with the transaction, Tom Sibirzeff has chosen to leave

Brain+’ new digital product for dementia, “CST–Therapist Companion” is ready for commercial launch in Denmark in Q4 2022 – one year ahead of plan

BRAIN+ A/S (BRAINP) · The Brain+ “CST-Therapist Companion” is a new digital product to deliver Cognitive Stimulation Therapy (CST), a globally recognized evidence-based non-pharmaceutical dementia therapy · The Danish market for the Brain+ digital CST products, of which CST-Therapist Companion is the first, is estimated at € 30 million · CST is used in 35 countries today, and Brain+ is the first to offer a digital version of the therapyBrain+ announces that its new digital product, “Cognitive Stimulation Therapy – Therapist Companion” (CST-Therapist Companion) will be launched in

Correction - missing MAR label in earlier press release - I-Tech AB (publ) Interim report Q2 2022

I-Tech AB (publ) (ticker: ITECH) publish the interim report for the second quarter 2022 Click here on the 26 August 2022 at 10:30 to follow the webcast  Click here to go to I-Tech's Financial Reports I-Tech AB (publ) issues a correction to the press release that was published earlier today. The correction refers to the fact that the press release lacked a MAR label with reference to the EU's Market Abuse Regulation (MAR). The following text should have been included in the press release:

Resolutions of EAB Group Plc’s Extraordinary General Meeting

EAB Group Plc, Stock Exchange Release, 26 August 2022, 12:45 p.m. (EET)   Resolutions of EAB Group Plc’s Extraordinary General Meeting   EAB Group Plc’s (“EAB”) Extraordinary General Meeting was held today 26 August 2022 in Helsinki, Finland. The General Meeting resolved to adopt the interim financial statements of the parent company and the consolidated financial statements of the group for the financial period 1 January to 30 June 2022.   EAB GROUP PLCBoard of Directors   Further information:   EAB Group Plc   Daniel Pasternack, CEO+358 50 569 3416

SSAB and POSCO organize a global conference for a greener future

Together for a Green Future! is the slogan for the Hydrogen Iron&Steel Making Forum 2022 in Stockholm this October. It will be hosted by SSAB and South Korean POSCO Group. The focus of the event is to provide a forum where steelmakers can promote collaboration and share advice, ideas and expertise to tackle the global climate change. Registration  Steel plays a critical role in developing industries and building communities. One can say our world is built using steel, which is why it is used in every aspect of our

Danske Hypotek: Interim Report January - June 2022

First half-year in briefJanuary – June 2022 (comparison with January – June 2020 in parentheses)· Operating profit was SEK 501 million (536 million) · Net interest income amounted to SEK 635 million (668 million) · Costs comprised SEK 127 million (77 million) · Reversals of reservations for credit losses amounted to SEK 16 million, for the corresponding period in 2021 reservations amounted to SEK 39 million. · Return on equity was 11.8 % (14.5 %) · The CET1 capital ratio was 16.3 % (16.0 %) Danske Hypotek’s covered bonds have the highest credit rating (AAA) from Standard

Biosergen completes the third cohort of BSG005 phase I trial

August 26, 2022: Biosergen AB (“Biosergen” or the “Company”) today announced that the Safety Review Committee has decided to continue the trial with cohort 4 in the Single Ascending Dose part of BSG005’s phase I trial.BSG005 is Biosergen’s lead development compound. It is a novel anti-fungal molecule from the group of polyene macrolides known for their broad anti-fungal and fungicidal effect, including on resistant and difficult-to-treat fungal strains, which make them unique within all antifungal drug classes.  The successful completion of the phase I trials will demonstrate, that BSG005

Glaston Oyj Abp - Managers' Transactions

Glaston Corporation     Stock Exchange Release, Managers' Transactions 26.8.2022 at 11.45Glaston Oyj Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Veli-Matti ReinikkalaPosition: Member of the Board/Deputy member Issuer: Glaston Oyj AbpLEI: 743700V3I7CLI3DJ8L62Notification type: INITIAL NOTIFICATIONReference number: 18862/7/6____________________________________________ Transaction date: 2022-08-25Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000369657Nature of the

Publication of a Prospectus

26 August 2022 International Personal Finance plc Publication of Prospectus The following prospectus (the "Prospectus") has been approved by the Financial Conduct Authority and is available for viewing: Prospectus dated 25 August 2022 relating to the International Personal Finance plc's €1,000,000,000 Euro Medium Term Note Programme. To view the full document together with the documents incorporated by reference, please paste the following URL into the address bar of your browser: http://www.ipfin.co.uk/en/investors/debt-funding-information.html For further information

Correction of previously issued announcement todat at 09:30 CET "Sivers Semiconductors invites to Capital Markets Day 2022"

Sivers Semiconductors AB issues a correction of press release 2022-08-26 at 09.30 regarding the invitation to Sivers Semiconductors Capital Markets Day in Stockholm. The correct date for the Capital Marlets Day 2022 is Monday 26 September, which has been corrected below. Sivers Semiconductors AB invites institutional investors, financial analysts and the media to a Capital Markets Day in Stockholm on Monday, September 26, 2022.The aim of the day is to increase the understanding of Sivers Semiconductors’ operations and markets after the acquisition of the US company MixComm, which has

Hynion in partnership with PDC Machines

Hynion has selected PDC Machines to supply compressors for their new hydrogen filling stations, which are set to be built in Västerås and Jönköping in Sweden.  These projects require dependable and robust compressors, as they represent a new generation of stations with the capacity to refuel dozens of trucks per day.  Each station will deliver hydrogen at 35 and 70 MPa and will service both light and heavy-duty vehicles.“We see this partnership as the start of an ambitious, long-term collaboration”, says Ulf Hafseld, CEO of Hynion. “Good dialogue, good products and good service are

Eric Johansson and Åsa Fredin moves their ownership in K-Fastigheter to Swedish endowment insurances

Eric Johansson, Head of business area Construction, and Åsa Fredin, Head of business area Project Development at K-Fast Holding AB (publ), have during August 26th, through their respective fully owned companies Aalto Holding AB and Åsa Fredin AB moved their ownership in K-Fastigheter to a respective Swedish endowment insurance. This will be reported in the PDMR transactions register at Finansinspektionen (the Swedish Financial Supervisory Authority). The transfer is only internally in Aalto Holding AB and Åsa Fredin AB whereby Eric Johansson and Åsa Fredins ownership in K-Fastigheter remain

Information from Interim report January-June 2022 Misen Energy AB (publ)

Following is a summary of the financial information given Interim report January - June 2022 (1H 2022) from Misen Energy AB (publ) published today. The complete report is attached and is available in both English and Swedish on the Company's website: https://misenenergy.se/repository/Financial_reports_ENG/Misen_Energy_Q2_2022_ENG.pdf  Results for April-June 2022 (within brackets same period 2021): · Consolidated operating group result KSEK -6,996 (-18,213) · Consolidated group net turnover: KSEK 0 (146) · Earnings per share: SEK -0.05 (-0.12) · Production of natural gas: at

Sivers Semiconductors invites to Capital Markets Day 2022

Sivers Semiconductors AB invites institutional investors, financial analysts and the media to a Capital Markets Day in Stockholm on Thursday, September 26, 2022.The aim of the day is to increase the understanding of Sivers Semiconductors’ operations and markets after the acquisition of the US company MixComm, which has made Sivers Wireless a strong global contender in 5G, SATCOM and radar. The Capital Markets Day will go into the company's unique offer within Sivers Photonics. Presentations will be held by group management as well as by customers and partners. Date: 26 September 2022

Arbitral award passed in Feelgood compulsory redemption proceedings

Terveystalo Plc Press Release 26 August 2022 at 10:30 EEST On 27 July 2021, Terveystalo Plc (“Terveystalo”) announced that its wholly owned subsidiary Terveystalo Healthcare Oy (“Terveystalo Healthcare”) had acquired in aggregate 97.42 percent of the shares and votes in Feelgood Svenska AB (publ) (“Feelgood”) after the completion of the recommended mandatory cash offer to the shareholders of Feelgood to tender all their shares in Feelgood to Terveystalo Healthcare for a consideration of SEK 5.70 (at the time, approximately EUR 0.566) in cash per share. Terveystalo further announced that

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 166 - 26 AUGUST 2022 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

BioStock: Spago Nanomedical on the autumn newsflow

During the second quarter, Lund-based Spago Nanomedical carried out a rights issue securing financial resources to keep up the pace of the development work with Tumorad, the company's radionuclide treatment for cancer. The company's second project, a new contrast agent for MRI diagnostics, is already in clinical trial. BioStock contacted CEO Mats Hansen for an update on the autumn news flow.Read the interview with Spago Nanomedical's CEO Mats Hansen at biostock.se: https://www.biostock.se/en/2022/08/spago-nanomedical-on-the-autumn-newsflow/ This is a press release from BioStock -

Composition of Kamux’s Shareholders’ Nomination Board

Kamux Corporation, Stock Exchange Release, 26.8.2022 at 10:00 Composition of Kamux’s Shareholders’ Nomination Board The largest shareholders of Kamux Corporation have nominated their representatives for the Shareholders’ Nomination Board for the term 2022–2023. The Shareholders’ Nomination Board consists of four members. The right to appoint members representing the shareholders belongs to the three shareholders whose proportions of the votes of all shares of the Company are the largest, according to the shareholders’ register held by Euroclear Finland Ltd on the first business day

Significant increase in demand for NIB’s financing

During the first six months of 2022, the Bank has seen a significant increase in demand for its financing. NIB agreed a total of EUR 2,203 million in new loans and disbursed EUR 2,142 million, compared to EUR 664 million and EUR 1,266 million respectively in the same period in 2021.The new lending was distributed across different sectors and countries and include sustainability-linked loans and NIB’s first purchase of a bond eligible under the Minimum Requirement for its own funds and Eligible Liabilities (MREL) issued by a financial institution. “In these times, the need for the Nordic

Endomines reports new, high-grade drill results from the Pampalo gold mine

Endomines AB, stock exchange release 26th August 2022 at 09:00 CET   Endomines is pleased to report drill results from the underground core drilling program carried out in the spring/summer 2022 at the Pampalo Gold Mine in Finland. The drill program consisted of fifty tree (53) diamond drill holes for a total of 4 330 m. Drill holes were targeted to the area between the 815 and 875 mine levels, representing the next sixty (60) vertical meters below the current production area.   Highlighted drill results include:   · T-1753 intersected 8.2 meters at 13.1 g/t gold,

RLS GLOBAL AB (PUBL) INTERIM REPORT, Q2, 2022

APRIL 1[st] – JUNE 30[th ](Previous year in brackets) · Net sales amounted to TSEK 397 (TSEK 244). · Earnings before interest and taxes (EBIT) amounted to MSEK -5,8 (MSEK 8,5). · Earning per share before dilution at SEK -0,09 (SEK 0,13). · Cash flow from operating activities amounted to TSEK -5 929 (TSEK -6 280). · Liquid assets at the end of the period MSEK 5,8 (MSEK 6,9). · Equity ratio was 43 % (87 %).  JANUARY 1[st] – JUNE 30[th ](Previous year in brackets) · Net sales amounted to TSEK 705 (TSEK 302). · Earnings before interest and taxes (EBIT) amounted

Enzymatica announces outcome of new rights issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. The Board of Directors for Enzymatica (”Enzymatica” or ”Company”) today announces the outcome of the new rights issue with preferential rights for existing shareholders that was published on 19 July 2022 (the “Rights issue”). The new rights issue was fully subscribed, and the Company will receive proceeds amounting to about SEK 74.7 million before issue

There are no items matching the current filter
There are no more items matching the current filter
Back to top